Skip to main content

Animations

MJFF Publications

7371 - 7380 of 9145 Results
Title
Year
  • Year
  • 2026
  • 2024
  • 2016
  • 2018
  • 2018
  • 2020
  • 2016
  • 2026
  • 2025
  • 2025
  • Summary Details
    OPEN
    Title: Clinical Progression in Alpha‐Synuclein Positive LRRK2 ‐ PD and Sporadic Parkinson's Disease: A Longitudinal Analysis
    Journal Name: Movement Disorders Clinical Practice
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1002/mdc3.70640
    Citation Count: 0
  • Summary Details
    OPEN
    Title: Conjugal Synucleinopathies: A Clinicopathologic Study
    Journal Name: Movement Disorders
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: OPEN
    License: other-oa
    DOI - Digital Object Identifier: 10.1002/mds.29783
    Citation Count: 3
  • Summary Details
    OPEN
    Title: The BioFIND study: Characteristics of a clinically typical Parkinson's disease biomarker cohort
    Journal Name: Movement Disorders
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1002/mds.26613
    Citation Count: 66
  • β2‐adrenoreceptor medications and risk of Parkinson disease
    2018
    Summary Details
    RESTRICTED
    Title: β2‐adrenoreceptor medications and risk of Parkinson disease
    Journal Name: Annals of Neurology
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1002/ana.25341
    Citation Count: 86
  • Summary Details
    OPEN
    Title: Sex differences in progression to mild cognitive impairment and dementia in Parkinson's disease
    Journal Name: Parkinsonism & Related Disorders
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1016/j.parkreldis.2018.02.007
    Citation Count: 141
  • Summary Details
    OPEN
    Title: Relationship of Cerebrospinal Fluid Vitamin B12 Status Markers With Parkinson's Disease Progression
    Journal Name: Movement Disorders
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1002/mds.28073
    Citation Count: 32
  • Reproducibility of locus coeruleus and substantia nigra imaging with neuromelanin sensitive MRI
    2016
    Summary Details
    RESTRICTED
    Title: Reproducibility of locus coeruleus and substantia nigra imaging with neuromelanin sensitive MRI
    Journal Name: Magnetic Resonance Materials in Physics, Biology and Medicine
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1007/s10334-016-0590-z
    Citation Count: 89
  • Summary Details
    OPEN
    Title: The emerging role and therapeutic targeting of autophagy-lysosome pathway in the pathogenesis of Parkinson’s disease
    Journal Name: Translational Neurodegeneration
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1186/s40035-026-00555-3
    Citation Count: 0
  • Summary Details
    OPEN
    Title: A meta-analysis of genetic variant pathogenicity and sex differences in UBQLN2-linked amyotrophic lateral sclerosis and frontotemporal dementia
    Journal Name: Neurobiology of Disease
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc
    DOI - Digital Object Identifier: 10.1016/j.nbd.2025.107127
    Citation Count: 1
  • Summary Details
    OPEN
    Title: Integrated Representations of Threat and Controllability in the Lateral Frontal Pole
    Journal Name: Journal of Cognitive Neuroscience
    Publisher: MIT Press
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1162/jocn.a.2418
    Citation Count: 2
We use cookies to ensure that you get the best experience. By continuing to use this website, you indicate that you have read our Terms of Service and Privacy Policy.